Yun Yeong Kim

ORCID: 0000-0002-7694-6148
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Breast Cancer Treatment Studies
  • Breast Lesions and Carcinomas
  • Cancer Risks and Factors
  • Advanced MRI Techniques and Applications
  • MRI in cancer diagnosis
  • Multiple and Secondary Primary Cancers
  • Advanced Breast Cancer Therapies
  • Traditional and Medicinal Uses of Annonaceae
  • Thyroid Cancer Diagnosis and Treatment
  • Breast Implant and Reconstruction
  • Health and Well-being Studies
  • Cancer and Skin Lesions
  • Cancer Diagnosis and Treatment
  • Thyroid and Parathyroid Surgery
  • HER2/EGFR in Cancer Research
  • Education and Learning Interventions
  • Health Systems, Economic Evaluations, Quality of Life
  • Cervical Cancer and HPV Research
  • Pregnancy and preeclampsia studies
  • Statistical Methods in Clinical Trials
  • Metastasis and carcinoma case studies
  • Endometrial and Cervical Cancer Treatments
  • Lymphatic System and Diseases
  • Women's cancer prevention and management
  • Marine Sponges and Natural Products

Gachon University Gil Medical Center
2017-2025

Gachon University
2016-2024

Daegu Health College
2021

Sogang University
2018

Purpose In-vivo proton magnetic resonance spectroscopy (MRS) is a non-invasive method of analyzing choline metabolism that has been used to predict breast cancer prognosis. A strong peak may be surrogate for aggressive tumor biology but its clinical relevance unclear. The present study assessed whether total (tCho), as measured by MRS, can late recurrence in patients with hormone receptor (HR)-positive, HER2-negative early cancer. Methods cohort included 261 HR+/HER2- who underwent...

10.1371/journal.pone.0311012 article EN cc-by PLoS ONE 2025-01-02

Background Personalized treatment for cancer patients is a hot topic of debate, particularly the decision to initiate chemotherapy in with Estrogen receptor (ER)-positive, HER2-negative tumors early stages breast (BC). Owing significant advancements information technology (IT) and genomics, clinicians are increasingly attaining therapeutic goals rapidly safely by effectively differentiating patient subsets that require chemotherapy. IBM Watson Oncology (WFO) cognitive computing system...

10.1371/journal.pone.0200100 article EN cc-by PLoS ONE 2018-07-06

The aim of this retrospective study was to investigate whether there are prognostically different subgroups among patients with pathologic N3 (pN3) breast cancer.The records 220 who underwent surgery for pN3 cancer from January 2006 September 2012 were reviewed. All received adjuvant therapy according standard protocols. primary outcome disease-free survival (DFS).Patients followed a median time 68.3 months after their (range, 10-122 months), during which 75 (34.1%) had developed disease...

10.4048/jbc.2016.19.2.163 article EN cc-by-nc Journal of Breast Cancer 2016-01-01

Long-term safety of pregnancy after breast cancer (BC) remains controversial, especially with respect to BC biological subtypes.We analyzed a population-based retrospective cohort from 2002 2017. Patient-level 1:1 matching was performed between pregnant and nonpregnant women. The study population categorized into 6 subtypes based on the combination prescribed therapies. Subanalyses were considering time diagnosis, systemic therapy, outcomes.We identified 544 matched women BC, who assigned...

10.4174/astr.2022.102.2.73 article EN Annals of Surgical Treatment and Research 2022-01-01

Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by authors. Any queries (other than missing content) should be directed to corresponding author article.

10.1002/bkcs.11436 article EN Bulletin of the Korean Chemical Society 2018-04-02

Purpose Idiopathic granulomatous mastitis (IGM) is a rare disease characterized by noncaseating inflammation of unknown origin. Because its clinical features are similar to those other type or breast cancer, accurate diagnosis and adequate treatment essential ensuring short symptom duration improving the quality life. Methods The clinical, radiologic, pathophysiologic, data for 43 patients diagnosed with IGM at Breast Cancer Center Gachon University Gil Medical between 2005 2016 were...

10.14449/jbd.2017.5.2.82 article EN Journal of Breast Disease 2017-12-29

<title>Abstract</title> Purpose In-vivo proton magnetic resonance spectroscopy (MRS) is a non-invasive method of analyzing choline metabolism that has been used to predict breast cancer prognosis. A strong peak may be surrogate for aggressive tumor biology but its clinical relevance unclear. The present study assessed whether total choline(tCho), as measured by MRS, can survival in patients with hormone receptor(HR)-positive, HER2-negative early cancer. Methods cohort included 560 who...

10.21203/rs.3.rs-4164614/v1 preprint EN cc-by Research Square (Research Square) 2024-04-03

Background Seromas frequently develop in patients who undergo total mastectomy with node surgery. We aimed to prospectively explore whether use of oxidized regenerated cellulose (ORC, SurgiGuard ® ) affects seroma formation after surgery (sentinel lymph biopsy (SLNB) or axillary dissection (ALND)). Materials and methods Ninety four breast cancer were enrolled the study underwent ALND SLNB. The randomized into two groups, one treated ORC plus closed suction drainage other alone. Results Mean...

10.1371/journal.pone.0267694 article EN cc-by PLoS ONE 2022-05-27

e13575 Background: Long-term safety of pregnancy after breast cancer still remained controversial, especially according to tumor subtypes. Prior results other studies have limitations short follow-up periods or small groups. Methods: We analyzed a population-based retrospective cohort data extracted from random sample 50% women aged between 20 and 60 years who were diagnosed with 2002 2017 in the Korean National Health Insurance Service database. Propensity score matching analysis for age...

10.1200/jco.2020.38.15_suppl.e13575 article EN Journal of Clinical Oncology 2020-05-20

Purpose In Korea, the incidence of breast cancer peaks in fifth decade, which is younger than that observed Western world. We conducted this study to compare clinical characteristics and prognostic factors women <35 ≥35 years old. Methods The medical records 969 patients treated for at Gil Medical Center from 2008 through 2012 were reviewed. Tumor characteristics, surgical methods, adjuvant therapies compared two groups. Results Number childbirths, family history, proportion postmenopausal...

10.14216/kjco.18001 article EN Korean Journal of Clinical Oncology 2018-06-30

Purpose: Follicular thyroid cancer (FTC) can frequently metastasize to distant organs, which worsens the prognosis.This study evaluated risk factors of metastasis in FTC.Methods: We retrospectively reviewed 149 patients diagnosed with primary FTC and underwent operations between 2001 2017.Results: The mean age all was 44.8±14.4 years 82.6% were female.The tumor size 3.44±1.77cm a total thyroidectomy performed 41.6% cases.The follow-up duration 65.4±43.5 months.Distant metastases occurred 8...

10.16956/jes.2019.19.1.1 article EN cc-by-nc Journal of Endocrine Surgery 2019-01-01

Objectives: For dental hygienists to have long-term self-satisfaction in the clinical practice and perform high-quality health work, it is an essential factor that helps improve oral of patients.On other hand, although are professional workers, their job lifespan reported be as low 10 years or less.Psychological anxiety factors felt can cited cause.Therefore, this study, we tried find out psychological feel field, investigate effect those on ability.Methods: This study conducted online...

10.15236/ijcpd.2021.17.3.139 article EN cc-by-nc International Journal of Clinical Preventive Dentistry 2021-09-30

Abstract Background: Genexol PM is a lyophilized polymeric micellar formulation of paclitaxel that delivers higher dose with lower vehicle-related toxicities than conventional formulations. This study was designed to evaluate the efficacy and safety genexol- doxorubicin combination in advanced Her-2 negative Breast cancer as first line treatment. Methods: Patients received Genexol-PM at 260mg/m2 on day 1 50mg/m2 3-week interval cycle. Six nine cycles chemotherapy were planned unless there...

10.1158/1538-7445.sabcs19-p2-15-11 article EN Cancer Research 2020-02-15
Coming Soon ...